| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/24/2001 | US6264962 Use of cinnamic acid or of at least one of its derivatives in a cosmetic composition |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | US6264928 Use of shogaols and gingerols for preparing deodorant compositions |
| 07/24/2001 | CA2201959C Photostable sunscreen composition comprising a dibenzoylmethane derivative and a polysaccharide alkylether and its uses |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051619A2 Genetically modified fibroblast cell |
| 07/19/2001 | WO2001051487A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | WO2001051470A1 Phenanthridine-n-oxides |
| 07/19/2001 | WO2001051464A1 Novel vitamin d analogues |
| 07/19/2001 | WO2001051069A1 Use of dictyotal extracts in the production of a topical composition |
| 07/19/2001 | WO2001051066A2 Reduction in bacterial colonization by administering bacteriophage compositions |
| 07/19/2001 | WO2001051051A2 AGENTS, SUCH AS NICOTINAMIDE OR cADPR FOR THE TREATMENT OF SKIN DISORDERS |
| 07/19/2001 | WO2001051048A1 Use of epigallocatechin-gallate for inhibiting angiogenesis |
| 07/19/2001 | WO2001051044A2 Substances for use in treating psoriasis |
| 07/19/2001 | WO2001051042A2 Treatment of diabetic ulcers |
| 07/19/2001 | WO2001051027A2 Polymer blends as biodegradable matrices for preparing biocomposites |
| 07/19/2001 | WO2001051023A1 Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin |
| 07/19/2001 | WO2001051022A1 Oral use of dehydroepiandrosterone and some of its derivatives as pigmentation regulators |
| 07/19/2001 | WO2001051014A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | WO2001051003A2 Use of lipid conjugates in the treatment of disease |
| 07/19/2001 | WO2001050994A1 Topical medicated bioadhesive compositions and methods of use and preparation thereof |
| 07/19/2001 | WO2001050873A1 Thickened oil compositions of edible oil |
| 07/19/2001 | WO2001050872A2 Method for produce sanitation using bacteriophages |
| 07/19/2001 | WO2001050866A2 Method and device for sanitation using bacteriophages |
| 07/19/2001 | WO2001009076A3 Retinoids for the treatment of emphysema |
| 07/19/2001 | WO2001005392A3 Method for treating chronic pain using mek inhibitors |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | WO1998033916A8 Secreted proteins and polynucleotides encoding them |
| 07/19/2001 | US20010008895 Reacting 17 beta-(alkoxycarbonyl)-3-one-4-aza-steroid with lithium tert-butylamide in an organic solvent |
| 07/19/2001 | US20010008888 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
| 07/19/2001 | CA2430501A1 Method for produce sanitation using bacteriophages |
| 07/19/2001 | CA2430500A1 Method and device for sanitation using bacteriophages |
| 07/19/2001 | CA2430498A1 Reduction in bacterial colonization by administering bacteriophage compositions |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397081A1 Novel vitamin d analogues |
| 07/19/2001 | CA2397068A1 Pharmaceutical and cosmetic carrier or composition for topical application |
| 07/19/2001 | CA2396996A1 Genetically modified fibroblast cell |
| 07/19/2001 | CA2396120A1 Treatment of diabetic ulcers |
| 07/19/2001 | CA2396087A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 07/19/2001 | CA2396071A1 Thickened oil compositions of edible oil |
| 07/19/2001 | CA2396026A1 Phenanthridine-n-oxides |
| 07/19/2001 | CA2366621A1 Use of epigallocatechin-gallate for inhibiting angiogenesis |
| 07/19/2001 | CA2366411A1 Topical medicated bioadhesive compositions and methods of use and preparation thereof |
| 07/18/2001 | EP1116725A1 Process for obtaining 17beta-(n-terc-butylcarbamoyl)-3-one-4-aza-steroids |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115747A1 Polymer complexes of glucuronoglucanes |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 07/18/2001 | EP1115708A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 07/18/2001 | EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors |
| 07/18/2001 | EP1115701A1 Arylsulfonanilide ureas |
| 07/18/2001 | EP1115434A1 Adhesive protein foam for surgical and/or therapeutic uses |
| 07/18/2001 | EP1115416A1 Use of substances with oxytocin activity in order to create cell regeneration |
| 07/18/2001 | EP1115398A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 07/18/2001 | EP1115395A1 ACTIVE ENANTIOMER OF RARgamma-SPECIFIC AGONIST |
| 07/18/2001 | EP1115375A1 Use of at least a10-hydroxy-2- decenoic acid derivative in a composition for promoting skin scaling |
| 07/18/2001 | EP1034171B1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 07/18/2001 | EP0823903B1 Heterocyclic diaryl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304320A Drug composition containing PGD antagonists for curing inthing |
| 07/18/2001 | CN1304312A Composition and method for treatment and preventing of arthritis and/or autoimmune diseases |
| 07/18/2001 | CN1304311A Bridged indenopyrrolocarbazoles |
| 07/18/2001 | CN1303869A Egg yellow antiinterleukin -8 antibody, preparation method and its application |
| 07/18/2001 | CN1303707A Compound tinae-eliminating liquor |
| 07/18/2001 | CN1303699A Shuangtian oil |
| 07/18/2001 | CN1303695A All-natural black hair-growing agent |
| 07/18/2001 | CN1303687A Quick-acting scarless burn, scald band bed sore ointment and its preparation method |
| 07/18/2001 | CN1303682A Preparation method of medicine for curing surgical diseases of traditional Chinese medicine |
| 07/18/2001 | CN1303677A Activator and inhibitor of profibrinolysin and agent of external use for skin for mating it |
| 07/18/2001 | CN1303664A Pigment compositions for dyeing hair |
| 07/18/2001 | CN1068591C 1,3-dihydro-1-(phenylalkyl)-2H-imdiazol-2-one derivatives having PDEIV and cytokine activity |
| 07/18/2001 | CN1068590C 1,3-dihydro-1-(phonylalkenyl)-2H-imidazol-2-one derivatives having PDEIV and cytokine inhibiting activity |
| 07/18/2001 | CN1068588C 1H-indole-3-acetamide splA2 inhibitors |
| 07/18/2001 | CN1068524C Medicine for curing intractable psoriasis |
| 07/18/2001 | CN1068514C Preparation of promoting hair growth |
| 07/18/2001 | CN1068513C Hair growth-promoting lotion |
| 07/17/2001 | US6262126 Semi-fluorinated alkanes and their use |
| 07/17/2001 | US6262122 Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile |
| 07/17/2001 | US6262117 Method and composition for treating acne |
| 07/17/2001 | US6262105 Method of enhancing hair growth |
| 07/17/2001 | US6262096 Aminothiazole inhibitors of cyclin dependent kinases |
| 07/17/2001 | US6262084 Compounds that inhibit the binding of integrins to their receptors |
| 07/17/2001 | US6262057 Pseudopolymorphic forms of 2-[2-[4-[Bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 07/17/2001 | US6262050 Topical composition containing capsazepine |
| 07/17/2001 | US6262046 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 07/17/2001 | US6262040 Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) |
| 07/17/2001 | US6262021 Wounds of the skin, bone, mucus, tendons, muscles or connective tissue in mammals. |
| 07/17/2001 | US6262020 Topical wound therapeutic compositions |
| 07/17/2001 | US6261606 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/17/2001 | US6261575 Skin-care agent for ageing skin |
| 07/17/2001 | US6261566 Cosmetic compositions containing mulberry extract and retinoids |
| 07/17/2001 | US6261544 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 07/17/2001 | CA2173543C Ceramide-type compounds, process for their preparation and uses thereof |
| 07/12/2001 | WO2001049822A2 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |